|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02607 SH PHARMA
Nominal 
10.800 -0.120 (-1.099%) Ranking Overview
Ranking based on 8 research report(s)
Average Ranking 2.13
|
Strong Buy (1)
0
|
Buy (2)
7
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 123.00 RMB (cts) | |
| Net Profit | 4,552.53 RMB (MIL) | DPS | 37.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 5,118.50 | 138.00 | 41.00 | -- | 5,834.00 | 4,939.00 |
| 2026 | 5,486.50 | 149.50 | 44.50 | -- | 6,841.00 | 5,392.00 |
| 2027 | 5,926.50 | 160.50 | 48.70 | -- | 6,322.00 | 5,589.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 5,547.00 | 149.90 | 45.00 | CITIGROUP | Buy | 15.30 | 11/11/2024 | |
| 2025 | 5,022.00 | 135.00 | -- | CITIC SEC | Buy | 15.00 | 31/03/2025 | |
| 2025 | 5,133.00 | 138.00 | 83.00 | CICC | OutPerform | 14.70 | 07/01/2025 | |
| 2025 | 5,141.00 | 139.00 | 38.51 | UBS | Buy | 14.50 | 31/03/2025 | |
| 2025 | 5,834.00 | 158.00 | 60.00 | CLSA | OutPerform | 13.80 | 31/10/2024 | |
| 2025 | 4,939.00 | 130.00 | 40.00 | HAITONG | OutPerform | 13.73 | 31/03/2025 | |
| 2025 | 4,994.00 | 135.00 | 40.70 | BANK OF AMERICA | Buy | 13.60 | 31/03/2025 | |
| 2025 | 5,104.00 | 138.00 | 41.00 | HSBC | Hold | 11.10 | 03/04/2025 | |
| 2026 | 6,149.00 | 166.10 | 49.90 | CITIGROUP | -- | -- | 11/11/2024 | |
| 2026 | 5,512.00 | 149.00 | -- | CITIC SEC | -- | -- | 31/03/2025 | |
| 2026 | 5,392.00 | 145.00 | 87.00 | CICC | -- | -- | 07/01/2025 | |
| 2026 | 5,710.00 | 154.00 | 42.67 | UBS | -- | -- | 31/03/2025 | |
| 2026 | 6,841.00 | 185.00 | 70.00 | CLSA | -- | -- | 31/10/2024 | |
| 2026 | 5,427.00 | 150.00 | 40.00 | HAITONG | -- | -- | 31/03/2025 | |
| 2026 | 5,461.00 | 148.00 | 44.50 | BANK OF AMERICA | -- | -- | 31/03/2025 | |
| 2026 | 5,414.00 | 146.00 | 44.00 | HSBC | -- | -- | 03/04/2025 | |
| 2027 | 5,880.00 | 159.00 | -- | CITIC SEC | -- | -- | 31/03/2025 | |
| 2027 | 6,322.00 | 171.00 | 48.91 | UBS | -- | -- | 31/03/2025 | |
| 2027 | 5,973.00 | 162.00 | 48.70 | BANK OF AMERICA | -- | -- | 31/03/2025 | |
| 2027 | 5,589.00 | 151.00 | 45.00 | HSBC | -- | -- | 03/04/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 16/04/2025 17:27 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 4,552,528 |
| %Change | 20.821% |
| EPS / (LPS) | RMB 1.230 |
| NBV Per Share (¥) | RMB 25.700 |